What approval does—and does not—tell you.

Approval belongs to an exact product and use. It does not spread to every product with a similar name.

Real examples

As of September 2026, semaglutide is the medicine sold as Ozempic and Wegovy, and tirzepatide is sold as Mounjaro and Zepbound. The brands are FDA-approved for diabetes, weight management or other named health conditions; each label says which uses apply.

The brand name and the non-brand, or generic, name both matter. So does whether it is a pill or shot and what the label says it is used for.

Ask for the current label

The FDA label explains what the exact medicine is approved for. It also holds the product-specific warnings and storage facts.

As of September 2026, there is no FDA-approved non-brand version—called a generic—of Ozempic, Wegovy, Mounjaro or Zepbound that can be marketed in the United States.

Read the public sources

These links support the factual parts of this page. They are not care businesses.

This page links to the public record behind each factual claim.